| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 27,286 | 18,384 | 27,583 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 27,286 | 18,384 | 27,583 | | | Operating Expenses | | Research Development | 39,189 | 29,191 | 28,252 | | Selling General and Administrative | 14,163 | 14,430 | 12,012 | | Non Recurring |
-
|
-
| 20,890 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26,066) | (25,237) | (33,571) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,947) | 5,620 | 1,304 | | Earnings Before Interest And Taxes | (33,013) | (19,617) | (32,267) | | Interest Expense | 222 | 509 | 1,725 | | Income Before Tax | (33,235) | (20,126) | (33,992) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (33,235) | (20,126) | (33,992) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (33,235) | (20,126) | (33,992) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($33,235) | ($20,126) | ($33,992) |
|
0.29% Nasdaq 
0.03 (0.43%) 
Income Statement
